Cox SR, Erisa KC, Kitonsa PJ, Nalutaaya A, Nantale M, Kayondo F, Mukiibi J, Mukiibi M, Nakasolya O, Dowdy DW, Katamba A, Kendall EA. Accuracy of C-Reactive Protein for Tuberculosis Detection in General-Population Screening and Ambulatory-Care Triage in Uganda. Ann Am Thorac Soc. 2024 Jun;21(6):875-883. doi: 10.1513/AnnalsATS.202308-752OC. PMID: 38259069; PMCID: PMC11160129.
Publication Category: Bioinformatics, Modeling & Biostatistics
Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community
Kendall EA, Kitonsa PJ, Nalutaaya A, Robsky KO, Erisa KC, Mukiibi J, Cattamanchi A, Kato-Maeda M, Katamba A, Dowdy D. Decline in prevalence of tuberculosis following an intensive case finding campaign and the COVID-19 pandemic in an urban Ugandan community. Thorax. 2024 Jan 22:thorax-2023-220047. doi: 10.1136/thorax-2023-220047. Epub ahead of print. PMID: 38050134.
The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates
Kasaie P, Pennington J, Gupta A, Dowdy DW, Kendall EA. The Impact of Preventive Treatment for Multidrug- and Rifampin-Resistant Tuberculosis Exceeds Trial-Based Estimates. Clin Infect Dis. 2024;78(1):133-143. doi:10.1093/cid/ciad557
Perceived stigma among people with TB and household contacts
Machavariani E, Nonyane BAS, Lebina L, Mmolawa L, West NS, Dowdy DW, Martinson N, Ahmad B, Hanrahan CF. Perceived stigma among people with TB and household contacts. Int J Tuberc Lung Dis. 2023 Sep 1;27(9):675-681. doi: 10.5588/ijtld.22.0670. PMID: 37608483; PMCID: PMC10443789.
Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing
Malhotra A, Thompson R, De Vos M, David A, Schumacher S, Sohn H. Determining cost and placement decisions for moderate complexity NAATs for tuberculosis drug susceptibility testing. PLoS One. 2023 Aug 24;18(8):e0290496. doi: 10.1371/journal.pone.0290496. PMID: 37616318; PMCID: PMC10449112.
Higher yield using an event-based vs. door-to-door approach for active case-finding for TB
Malhotra A, Mukiibi J, Kitonsa PJ, Nalutaaya A, Kamoga CE, Robsky KO, Isooba D, Nantale M, Nakasolya O, Kayondo F, Mukiibi M, Kiyonga R, Dowdy DW, Katamba A, Kendall EA.
Number Needed to Screen for Tuberculosis Disease Among Children: A Systematic Review
Robsky KO, Chaisson LH, Naufal F, Delgado-Barroso P, Alvarez-Manzo HS, Golub JE, Shapiro AE, Salazar-Austin N.
Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta?
Checkley W. Tuberculosis, Wildfires, and Case-crossover Studies: An Epidemiological Trifecta? Am J Respir Crit Care Med. 2023 Feb 1;207(3):242-243. doi: 10.1164/rccm.202210-1936ED. PMID: 36315435; PMCID: PMC9896637.
Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
Thompson RR, Nalugwa T, Oyuku D, Tucker A, Nantale M, Nakaweesa A, Musinguzi J, Reza TF, Zimmer AJ, Ferguson O, Turyahabwe S, Joloba M, Cattamanchi A, Katamba A, Dowdy DW, Sohn H. Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis. Lancet Glob Health. 2023 Feb;11(2):e278-e286. doi: 10.1016/S2214-109X(22)00509-5. PMID: 36669808; PMCID: PMC9848406.
Infectious and clinical tuberculosis trajectories: Bayesian modeling with case finding implications